EFIB 2015 returns to Brussels
Catalysing the transition towards a circular, bioeconomy
Brussels, 27-29 October 2015– For the 8th edition of this market-leading event, EFIB, co-organised by EuropaBio, SmithersRapra and Bio.be, returns to Brussels, Europe’s capital, for three days of discussion, debate and networking.
Secretary General of EuropaBio, Nathalie Moll, noted that ‘many people still don’t realise the huge asset Europe has in its Industrial biotech sector. We have the technology to be part of a renewable revolution, enabling us to dramatically reduce our dependence on fossil carbon and use our resources more efficiently and sustainably in the production of a broad range of every day products. EFIB is about highlighting this potential and identifying ways to harness it’.
CEOs of key biobased innovators such as Corbion, Metsa and Novamont will join policy makers and speakers from the Ellen MacArthur Foundation, the European Climate Foundation, Accenture, Carlsberg, Interface, Zero Waste Europe, FrieslandCampina, Jaguar Landrover and Lego to share their insights on the opportunities and challenges they face in introducing smarter, more sustainable policies, products and processes.
Commenting on the event, Stephan Tanda, Managing Board Member of Royal DSM and Chair of EuropaBio’s Industrial Biotech Council said: ‘This year EFIB takes place at a crucial moment in the development of an EU circular economy strategy, in the run-up to the biggest EU conference ever addressing investment in the bioeconomy and with Climate talks at COP21 in Paris on the horizon. Industrial Biotech will play a key role in creating jobs and growth in the EU, in enabling our transition towards a renewables-based future and in cutting GHG emissions. EFIB brings together the best and the brightest new ideas and solutions with the right people to develop them.’
For media inquiries, please contact:
Smithers Rapra Marketing and Press
Telephone: +44 13782 802085
Secretary General Bio.be
Telephone: +32 2 238 98 44
EuropaBio, the European Association for Bioindustries, promotes an innovative and dynamic European biotechnology industry. EuropaBio and its members are committed to the socially responsible use of biotechnology to improve quality of life, to prevent, diagnose, treat and cure diseases, to improve the quality and quantity of food and feedstuffs and to move towards a biobased and zero-waste economy. EuropaBio represents 77 corporate and associate members and bio regions, and 16 national biotechnology associations in turn representing over 1800 biotech SMEs.
About Smithers Rapra:
Smithers Rapra is the world leader in rubber, plastics, polymer and composites expertise. We have been delivering market leading events for the bioeconomy for more than a decade. Our global portfolio of events includes more than 10 leading industry conferences on biomaterials, polymer technologies, sustainability and novel materials. Our information business also provides member benefits, market forecasts and analysis.
bio.be is the federation of Belgian companies active in the biotechnology and biosciences and is part of essenscia (chemistry and life sciences). bio.be represents the interests of its members as regards legislation and standards at various policy levels (Belgium, EU, OECD). Its mission is to create a stable legal framework in line with the trend for innovation, an essential factor for the economic sustainability and growth of employment in this sector.
To this end, bio.be keeps a close eye on the different policies and organizes consultation with the involved actors. bio.be interacts directly with its members through its working groups. The working group ‘white biotechnology’ is dealing with the industrial biotechnology and the biobased economy.